Official Publications Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
06:00:02 29/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 291.50 USD | -1.66% |
|
-1.25% | +46.13% |
| 21/08 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 20/08 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Official Publications
| 05/08 | 1st-half-year results | CO |
| 05/08 | SEC Filing 10Q-2 | CO |
| 05/08 | SEC Filing 8K | CO |
| 11/05 | Shareholders meeting voting results | CO |
| 07/05 | SEC Filing 10Q-1 | CO |
| 07/05 | 1st quarter results | CO |
| 07/05 | SEC Filing 8K | CO |
| 31/03 | Proxy Statments | CO |
| 25/02 | SEC Filing 8K | CO |
| 18/02 | Slide show results | CO |
| 18/02 | SEC Filing 8K | CO |
| 18/02 | Annual results | CO |
| 18/02 | SEC Filing 10K | CO |
| 05/11 | 3rd quarter results | CO |
| 05/11 | SEC Filing 10Q-3 | CO |
| 05/11 | SEC Filing 8K | CO |
| 06/08/25 | Slide show half-year results | CO |
| 06/08/25 | 1st-half-year results | CO |
| 06/08/25 | SEC Filing 10Q-2 | CO |
| 06/08/25 | SEC Filing 8K | CO |
| 20/05/25 | Shareholders meeting voting results | CO |
| 07/05/25 | 1st quarter results | CO |
| 07/05/25 | SEC Filing 10Q-1 | CO |
| 07/05/25 | SEC Filing 8K | CO |
| 02/04/25 | Proxy Statments | CO |
- Stock Market
- Stocks
- CRL Stock
- News Charles River Laboratories International, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
















